Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Novateor Research Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.67%.
The historical rank and industry rank for Novateor Research Laboratories's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:542771'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3.39 Med: 0.66 Max: 10.4
Current: 1.71
During the past 10 years, Novateor Research Laboratories's highest ROC (Joel Greenblatt) % was 10.40%. The lowest was -3.39%. And the median was 0.66%.
BOM:542771's ROC (Joel Greenblatt) % is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 11.99
vs BOM:542771: 1.71
Novateor Research Laboratories (BOM:542771) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories ROC (Joel Greenblatt) % Chart
BOM:542771 vs PG, CL, KVUE: ROC (Joel Greenblatt) % Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's ROC (Joel Greenblatt) % falls into.
Novateor Research Laboratories ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 2.67% mean?
Novateor Research Laboratories (BOM:542771) has a ROC (Joel Greenblatt) % of 2.67% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Novateor Research Laboratories and its competitors. This is 305% above median its historical median of 0.66.
Is Novateor Research Laboratories' ROC (Joel Greenblatt) % too high?
Novateor Research Laboratories' current ROC (Joel Greenblatt) % of 2.67% is 305% above median its 10-year median of 0.66. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 11.99. Novateor Research Laboratories' value of 2.67% is 77.7% below this industry median. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' ROC (Joel Greenblatt) % compare to PG and CL?
Novateor Research Laboratories' ROC (Joel Greenblatt) % of 2.67% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROC (Joel Greenblatt) % is 11.99. Novateor Research Laboratories' value of 2.67% is 77.7% below this benchmark. While the company's 10-year median is 0.66 vs. the industry median of 11.99, Novateor Research Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 11.99, based on 1,987 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novateor Research Laboratories's current ROC (Joel Greenblatt) % of 2.67% is 77.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current ROC (Joel Greenblatt) % is 2.67%, which is 305% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current ROC (Joel Greenblatt) % of 2.67%. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.00 — trading 61.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 2.67%, which is 305% above median its 10-year median of 0.66 and 77.7% below the Consumer Packaged Goods industry median of 11.99. Novateor Research Laboratories' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current ROC (Joel Greenblatt) % is 2.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.00 is trading 61.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
ROC (Joel Greenblatt) %: 2.67% (305% above median its 10-year median of 0.66)
GF Value™: ₹83.64 vs. price of ₹32.00 (61.7% below fair value)
Industry Position: 77.7% below the Consumer Packaged Goods median
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
